It takes unwavering focus to deliver life-changing treatments
Get the facts about the safety of our devices
Learn more
ELUVIA™ DRUG-ELUTING VASCULAR STENT SYSTEM
Superior Results in the first head-to-head DES SFA Trial1
Learn more about the Eluvia Clinical Program
THERE'S AN ALTERNATIVE TO WARFARIN
FOR PEOPLE WHO NEED ONE. IT'S CALLED WATCHMAN™.
A one-time procedure that effectively reduces the risk of stroke in patients with non-valvular atrial fibrillation.
See How It Works
IT TAKES IMAGINATION
TO MAKE
SCIENCE MORE
EFFICIENT
That’s the difference between making devices and making progress.
Get to Know Us
Healthcare Professionals
Explore our breakthrough products that make a meaningful difference in patient's lives.
Administrators
Discover resources for Cardiovascular, Gastroenterology and Urology administrators.
Patients & Caregivers
Learn about living with an implanted device, explore health conditions and treatment options, and get support.
Patient Stories
The Safety Of Our
Urogynecological Mesh
Resources for patients and physicians
Rewarding Careers
Improving Health
Advance your career. Work at the foremost of medical innovation. And make a meaningful impact on lives around the globe.
Life-Changing Ideas
Wanted
We're always looking for groundbreaking ideas for new products or ways to improve existing ones.
Doing Business the
Right Way
Discover our commitment to doing business sustainably and responsibly in communities around the world.
2018 Annual Meeting
of Stockholders
Our 2018 Annual Meeting of Stockholders took place on Thursday, May 10, 2018.
News
Boston Scientific to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
Boston Scientific Announces Results for Fourth Quarter and Full Year 2018
New Four-Year Data Demonstrate Rezūm™ Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms
Boston Scientific Launches Vercise™ Primary Cell and Vercise Gevia™ Deep Brain Stimulation Systems with Directional Leads
Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement
Boston Scientific Announces Preliminary Unaudited Sales for the Fourth Quarter and Full Year 2018
Boston Scientific Announces Conference Call Discussing Fourth Quarter 2018 Financial Results And Investor Update At NANS 2019